GGFG-PAB-Exatecan TFA is a drug-linker conjugate designed for antibody-drug conjugate (ADC) synthesis, combining the potent topoisomerase I inhibitor Exatecan with a cleavable GGFG-PAB linker. This construct is utilized in research for developing targeted cancer therapies and has been evaluated in both in vitro and in vivo preclinical studies.
Molecular Weight:
1016.95
Formula:
C49H48F4N8O12
Target:
Topoisomerase,Drug-Linker Conjugates for ADC
* VAT and and shipping costs not included. Errors and price changes excepted
